Snowden Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,598
| Closed | -$293K | – | 1261 |
|
|
2025
Q1 | $293K | Buy |
4,598
+73
| +2% | +$4.66K | 0.01% | 992 |
|
|
2024
Q4 | $550K | Sell |
4,525
-2
| -0% | -$243 | 0.02% | 738 |
|
|
2024
Q3 | $565K | Buy |
4,527
+285
| +7% | +$35.6K | 0.02% | 716 |
|
|
2024
Q2 | $670K | Sell |
4,242
-56
| -1% | -$8.85K | 0.02% | 636 |
|
|
2024
Q1 | $556K | Buy |
4,298
+209
| +5% | +$27.1K | 0.02% | 715 |
|
|
2023
Q4 | $394K | Sell |
4,089
-46
| -1% | -$4.44K | 0.02% | 803 |
|
|
2023
Q3 | $501K | Sell |
4,135
-178
| -4% | -$21.6K | 0.02% | 652 |
|
|
2023
Q2 | $494K | Buy |
+4,313
| New | +$494K | 0.02% | 743 |
|
|
2022
Q1 | – | Sell |
-11
| Closed | – | – | 1940 |
|
|
2021
Q4 | $0 | Buy |
+11
| New | – | ﹤0.01% | 2147 |
|